Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ability to learn handling of inhaler devices in COPD
2016-001435-13Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Critical handling errors per device. Started Jun 2016; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-001435-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001435-13.